Moderna Is Developing Vaccines to Target Covid-19 Variants

Apr.06 -- Noubar Afeyan, co-founder at Moderna Inc and CEO at Flagship Pioneering Inc, discusses the new finding that their Covid-19 vaccine still works at least six months after patients get the second dose. He shares how soon he thinks there will be more data on vaccine for children. Noubar also talks about the new appointments of CEO-partners at his company, Flagship Pioneering. He speaks to Emily Chang on "Bloomberg Technology".